EDGAR Filing Documents for 0001104659-16-111218

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001104659-16-111218

Filing Date

2016-04-13

Accepted

2016-04-13 14:21:24

Documents

Period of Report

2016-04-30

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	a16-6364_36k.htm	6-K	17456
2	EX-99.1	a16-6364_3ex99d1.htm	EX-99.1	38811
3	EX-99.2	a16-6364_3ex99d2.htm	EX-99.2	137279
4	EX-99.3	a16-6364_3ex99d3.htm	EX-99.3	9731
5	EX-99.4	a16-6364_3ex99d4.htm	EX-99.4	12009
6	EX-99.5	a16-6364_3ex99d5.htm	EX-99.5	6600
7	GRAPHIC	g63643msi001.jpg	GRAPHIC	2938
8	GRAPHIC	g63643mqi001.jpg	GRAPHIC	2938
9	GRAPHIC	g63643moi001.jpg	GRAPHIC	2938
10	GRAPHIC	g63643mui001.gif	GRAPHIC	60170
11	GRAPHIC	g63643mui002.gif	GRAPHIC	64615
12	GRAPHIC	g63643mmi001.jpg	GRAPHIC	2938
	Complete submission text file	0001104659-16-111218.txt		411105

Mailing Address ?STERGADE 24A, 1 COPENHAGEN G7 1100

Business Address ?STERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242

Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)